CentriMag Circulatory Support System

FDA Premarket Approval P170038

Pre-market Approval Supplement Details

Temporary circulatory support for up to 30 days for one or both sides of the heart to treat postcardiotomy patients who fail to wean from cardiopulmonary bypass, providing a bridge to decision when it is unclear whether the patient's heart will recover or whether the patient will need alternative, longer-term therapy

DeviceCentriMag Circulatory Support System
Generic NameVentricular (assist) Bypass
ApplicantAbbott
Date Received2017-11-24
Decision Date2019-12-06
PMAP170038
SupplementS
Product CodeDSQ 
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Abbott 6035 Stoneridge Drive pleasanton, CA 94588

Supplemental Filings

Supplement NumberDateSupplement Type
P170038Original Filing
S010 2022-04-13 30-day Notice
S009 2022-03-15 30-day Notice
S008 2021-08-24 135 Review Track For 30-day Notice
S007 2021-08-02 Normal 180 Day Track No User Fee
S006 2021-07-08 30-day Notice
S005 2020-07-31 Normal 180 Day Track No User Fee
S004
S003 2020-04-01 30-day Notice
S002
S001 2020-01-08 Normal 180 Day Track No User Fee

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.